Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Frassoni

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Haematologica|May 21, 2009
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasmsDavide Bagnara, Adalberto Ibatici, Mirko Corselli, et al.
Blood|October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remissionFranco Locatelli, Myriam Labopin, Juan Ortega, et al.
Oncotarget|December 30, 2016
A novel assay to detect calreticulin mutations in myeloproliferative neoplasmsValentina Rosso, Jessica Petiti, Enrico Bracco, et al.
Blood|June 28, 2003
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrowNorbert C Gorin, Myriam Labopin, Vanderson Rocha, et al.
Clinical Science (London, England : 1979)|June 30, 2010
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factorsTeresa Rampino, Marilena Gregorini, Giulia Bedino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Francesco Frassoni, et al.
Plos One|December 15, 2010
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosisVittorio Rosti, Elisa Bonetti, Gaetano Bergamaschi, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Blood|October 18, 2002
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)Loïc Fouillard, Myriam Labopin, Norbert-Claude Gorin, et al.
Haematologica|May 13, 2008
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remissionLoic Fouillard, Myriam Labopin, Alois Gratwohl, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Haematologica|May 21, 2009
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasmsDavide Bagnara, Adalberto Ibatici, Mirko Corselli, et al.
Blood|October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remissionFranco Locatelli, Myriam Labopin, Juan Ortega, et al.
Oncotarget|December 30, 2016
A novel assay to detect calreticulin mutations in myeloproliferative neoplasmsValentina Rosso, Jessica Petiti, Enrico Bracco, et al.
Blood|June 28, 2003
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrowNorbert C Gorin, Myriam Labopin, Vanderson Rocha, et al.
Clinical Science (London, England : 1979)|June 30, 2010
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factorsTeresa Rampino, Marilena Gregorini, Giulia Bedino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Francesco Frassoni, et al.
Plos One|December 15, 2010
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosisVittorio Rosti, Elisa Bonetti, Gaetano Bergamaschi, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Blood|October 18, 2002
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)Loïc Fouillard, Myriam Labopin, Norbert-Claude Gorin, et al.
Haematologica|May 13, 2008
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remissionLoic Fouillard, Myriam Labopin, Alois Gratwohl, et al.
Pageof 11